Pharmeyes Cayman’s HK IPO Application Lapses; Pioneer of Healthcare Distribution Digital Management in China
NewTimeSpace News: As disclosed by HKEX, the Main Board listing application of Pharmeyes Cayman Holding Limited, filed on December 2, 2025, has recently lapsed upon the expiry of the six-month validity period. CCB International acted as the sole sponsor at the time of submission. The company is a pioneer and leader in healthcare distribution digital management in China. It launched China’s first channel data direct connection solution in 2009 and ranked second among third-party channel digital service providers for pharmaceutical and medical device enterprises by revenue in 2024.
NewTimeSpace News: Per official HKEX filings, Pharmeyes Cayman Holding Limited’s Hong Kong Main Board IPO application submitted on 2 December 2025 has expired after the six-month statutory period. CCB International previously served as the sole sponsor for the listing filing.
As a pioneer and leader in healthcare distribution digital management in China, Pharmeyes builds a full-factor intelligent data platform for the healthcare industry, anchored in massive data assets and industry-specific knowledge bases, delivering data-empowered solutions across the entire product lifecycle of healthcare enterprises. In 2009, it pioneered the channel data direct connection solution in China’s pharmaceutical and medical device sector. According to Frost & Sullivan, by 2024 revenue, the company ranks second among domestic third-party channel digital service providers for pharmaceutical and medical device enterprises.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
- Guotai CSI 800 Automobile And Parts ETF (516110) rises 1.38%, with the latest margin financing purchase amount reaching 1.0198 million yuan
- China Southern CSI SWS Non-Ferrous Metal ETF(512400) rises 1.69%, with a net inflow of 283 million yuan over the past 5 trading days
- Hang Seng TECH Index ETF (03032.HK) Rises 2.63%, Turnover Reaches HKD 228 Million
